Veritas Pharma Inc. Reports Earnings Results for the Second Quarter Ended October 31, 2020
Veritas Pharma Inc. announced earnings results for the second quarter ended October 31, 2020. For the second quarter, the company announced net loss was CAD 264,679 compared to CAD 255,439 a year ago. Basic loss per share was CAD 0.02 compared to CAD 0.02 a year ago. For the half year, net loss was CAD 408,976 compared to CAD 1.153 million a year ago. Basic loss per share was CAD 0.03 compared to CAD 0.09 a year ago.